Fdc Ltd. · NSE:FDC

Fdc — Q1 FY2023 Earnings Presentation

14 slides from Fdc's earnings presentation

  1. Slide 1: FDC Limited Investor Presentation Q1FY23

    FDC LIMITED Investor Presentation Q1FY23 www.fdcindia.com 1

  2. Slide 2: Disclaimer

    DISCLAIMER This report may contain certain statements that might be considered forward looking. These statements are subject to certain risk and uncertainties, since they are based on certain assumptions and expectations of future events. Actual results may differ materially from those expressed in

  3. Slide 3: Platform to deliver sustainable value

    Platform to deliver sustainable value 1 2 3 Best-in-class manufacturing Strong Domestic Business facilities & regulatory Strong Financials  Multiple levers, high growth track record brands to anchor growth  Portfolio of high quality  High Return on Capital  Zifi – Category Creator in manufacturi

  4. Slide 4: Multiple Levers to drive growth

    1(a) Multiple Levers to drive growth 3% 1% 5% 3% Anti-Infectives GI 4% Revenue 34% VMN 6% Derma Mix Domestic, Ophthal / Otologicals Export, 14% 86% 7% Cardiac Gynaec. 9% Respiratory Anti-Viral 28% Others Domestic Secondary Sales Export Sales 13% 68% 9% 8% 29% 10% 1% -25% 1,373 1,382 1,500 1,691 1,82

  5. Slide 5: Multiple Top Brands to anchor growth

    1(a) Multiple Top Brands to anchor growth Brand Molecule Rank Rs. Crs MS % Electral Oral Electrolytes ❶ 319 73.2% Zifi Cefixime ❶ 301 24.3% Enerzal Energy Drinks ❶ 137 41.8% Vitcofol Folic acid + Cyanocobalamin + Nicotinamide ❽ 82 2.6% Zifi CV Cefixime + Clav. ❶ 71 44.9% Zathrin Azithromycin ❹ 60 4.

  6. Slide 6: Electral – Category Creator & Consistent Leader in Oral Rehydration Salts

    1(b) Electral – Category Creator & Consistent Leader in Oral Rehydration Salts Electral –Brand synomous with product category In an otherwise fragmented market (Market Share) (Market Shares of Other Players) Market Share in MAT Jun 20 Market Share in MAT Jun 22 13.3% 13.3% 75.3% 71.8% 73.2% 3.8% MAT

  7. Slide 7: Zifi – Category Leader in Cefixime

    1(c) Zifi – Category Leader in CEFIXIME Zifi – Consistent Category Leader In an otherwise fragmented market (Market Share) (Market Shares of Other Players) Market Share in MAT Jun 20 Market Share in MAT Jun 22 21.87% 22.85% 24.2% 24.4% 24.3% MAT Jun 20 MAT Jun 21 MAT Jun 22 5.74% 6.10% 5.51% 5.49% 5

  8. Slide 8: Enerzal – Category Leader in Energy Drinks

    1(d) Enerzal– Category Leader in Energy Drinks Enerzal – Consistent Category Leader In an otherwise fragmented market (Market Share) (Market Shares of Other Players) Market Share in MAT Jun 20 Market Share in MAT Jun 22 27.8% 24.7% 42.3% 41.6% 41.8% 15.9% 16.3% MAT Jun 20 MAT Jun 21 MAT Jun 22 12.9%

  9. Slide 9: Manufacturing Facilities

    2 (a) Manufacturing Facilities Sinnar Sinnar Dosage Form Baddi Goa 1/2 Goa 3 Waluj (Food) (Form) Tablet/Capsule Baddi Dry Syrup Liquid Oral Powder Ophthalmic Ear Drops Sinnar - Food Plant Foods Waluj Sinnar – Form Plant Roha Goa (3 Facilities) API Plant Food Plant Formulation Plant Source: Internal

  10. Slide 10: Top Countries: Export Sale of APIs & Formulations Q1FY23

    2 (b) TOP 10 Countries: Export Sale of APIs & Formulations Q1FY23 Export Formulation Sales - 53Crs Export API Sales - 17crs 12% 16% 2% 19% 2% USA Japan 2% Ethiopia South Korea Malaysia France 3% New Zealand 4% Germany 13% 3% United Kingdom USA 4% 3% South Africa Bangladesh 52% Tanzania 4% UAE 5% Nep

  11. Slide 11: Quarterly Performance

    3(a) Quarterly Performance Sales (in Crs) YOY Sales Growth % 45% 8% 8% 11% 5% -6% 6% 3% 376 332 312 445 396 341 337 493 Q2FY21 Q3FY21 Q4FY21 Q1FY22 Q2FY22 Q3FY22 Q4FY22 Q1FY23 EPS in Rs EBITDA % 34% 31% 28% 26% 19% 20% 17% 9% 5.33 4.18 2.49 5.93 4.36 1.87 0.85 4.37 Q2FY21 Q3FY21 Q4FY21 Q1FY22 Q2FY22

  12. Slide 12: Quarterly Performance

    3(a) Quarterly Performance in crs. (except EPS) Q1FY23 Q1FY22 YoY % Revenue from operations Revenue from operations 493 445 11% Other income 19 23 -17% FY21 445 Total Income 512 468 9% FY22 493 Operating Expenses 413 331 25% EBITDA 99 137 -28% Finance Cost 0.7 0.8 -13% Depreciation 9 9 -2% EPS Profi

  13. Slide 13: For updates and company information, please visit our website

    For updates and company information, please visit our website i.e. www.fdcindia.com For specific queries, kindly email on investors@fdcindia.com

  14. Slide 14: Thank you

FDC — Q1 FY2023 Earnings Presentation on 6ix